Benitec Biopharma Inc.
BNTC
$13.59
-$0.305-2.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.42M | -20.86M | -21.75M | -21.69M | -21.81M |
| Total Depreciation and Amortization | 353.00K | 352.00K | 343.00K | 336.00K | 339.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.26M | 1.18M | 831.00K | 503.00K | 386.00K |
| Change in Net Operating Assets | -1.95M | -83.00K | 1.17M | 648.00K | 3.02M |
| Cash from Operations | -21.75M | -19.41M | -19.40M | -20.21M | -18.07M |
| Capital Expenditure | -191.00K | -179.00K | -179.00K | -180.00K | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -191.00K | -179.00K | -179.00K | -180.00K | -1.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 82.53M | 64.69M | 73.92M | 30.92M | 30.92M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.93M | -2.93M | -5.89M | -2.96M | -2.96M |
| Cash from Financing | 79.60M | 61.77M | 68.03M | 27.96M | 27.96M |
| Foreign Exchange rate Adjustments | 300.00K | -146.00K | -8.00K | 18.00K | -54.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 57.96M | 42.03M | 48.44M | 7.59M | 9.84M |